Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease-Reference-Cited by-同舟云学术

Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease

Published:2013-12 Issue:2 Volume:231 Page:308-314
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Yunoki Kei,Naruko Takahiko,Inaba Mayumi,Inoue Takeshi,Nakagawa Masashi,Sugioka Kenichi,Ohsawa Masahiko,Iwasa Yoko,Komatsu Ryushi,Itoh Akira,Haze Kazuo,Yoshiyama Minoru,Becker Anton E.,Ueda Makiko

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients;Tsimikas;J Am Coll Cardiol,2006

2. Myeloperoxidase and cardiovascular disease;Nicholls;Arterioscler Thromb Vasc Biol,2005

3. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro;Podrez;J Clin Invest,1999

4. Neutrophil infiltration of culprit lesions in acute coronary syndromes;Naruko;Circulation,2002

5. Prognostic value of myeloperoxidase in patients with chest pain;Brennan;N Engl J Med,2003

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Polyphenols in Modulating PON1 Activity Regarding Endothelial Dysfunction and Atherosclerosis;International Journal of Molecular Sciences;2024-03-04

2. Myeloperoxidase activity predicts atherosclerotic plaque disruption and atherothrombosis;2023-10-13

3. Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease;Expert Review of Cardiovascular Therapy;2023-10-03

4. Impact of obesity on liver function tests: is nonalcoholic fatty liver disease the only player? A review article;Porto Biomedical Journal;2023-09

5. The role of HDL-related myeloperoxidase (MPO) and paraoxonase 1 (PON1) in terms of coronary artery disease in Hashimoto’s thyroiditis;Comparative Clinical Pathology;2023-02-13